Showing 821 - 840 results of 933 for search '"rheumatologist"', query time: 0.09s Refine Results
  1. 821

    Relative incidence of interstitial lung diseases in Brazil by Simone Lobo Krupok Matias, Carlos Alberto de Castro Pereira, Maria Raquel Soares, Flávia Castro Velasco Fernandes, Maria Auxiliadora Carmo Moreira, Fernanda Maciel de Aguiar Baptista, Tarciane Aline Prata, Gediel Cordeiro Junior, Eliane Viana Mancuzo

    Published 2024-03-01
    “…These results highlight the need for close collaboration between pulmonologists and rheumatologists, the importance of detailed questioning of patients in regard with potential exposure to antigens, and the need for public health campaigns to stress the importance of avoiding such exposure.…”
    Get full text
    Article
  2. 822

    Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox by Alexandra Nagy, Erik Palmer, Lorinc Polivka, Noemi Eszes, Krisztina Vincze, Eniko Barczi, Aniko Bohacs, Adam Domonkos Tarnoki, David Laszlo Tarnoki, György Nagy, Emese Kiss, Pal Maurovich-Horvat, Veronika Müller

    Published 2022-02-01
    “…The aim of our study is to evaluate the clinical characteristics and predictors of lung function changes in SSc-ILD patients treated in a real-world setting. (2) Methods: All SSc-ILD cases previously confirmed by rheumatologists and a multidisciplinary ILD team between January 2017 and June 2019 were included (<i>n</i> = 54). …”
    Get full text
    Article
  3. 823
  4. 824

    Harnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical training by Alfredo Madrid-García, Zulema Rosales-Rosado, Dalifer Freites-Nuñez, Inés Pérez-Sancristóbal, Esperanza Pato-Cour, Chamaida Plasencia-Rodríguez, Luis Cabeza-Osorio, Lydia Abasolo-Alcázar, Leticia León-Mateos, Benjamín Fernández-Gutiérrez, Luis Rodríguez-Rodríguez

    Published 2023-12-01
    “…A dataset, RheumaMIR, of 145 rheumatology-related questions, extracted from the exams held between 2010 and 2023, was created for that purpose, used as a prompt for the LLM, and was publicly distributed. Six rheumatologists with clinical and teaching experience evaluated the clinical reasoning of the chatbots using a 5-point Likert scale and their degree of agreement was analyzed. …”
    Get full text
    Article
  5. 825

    Retrospective analysis of the effectiveness of local corticosteroid therapy in children with oligoarticular juvenile idiopathic arthritis by A. N. Kozhevnikov, N. A. Pozdeeva, M. S. Nikitin, O. N. Maricheva, T. V. Murashko, N. Yu. Orlova, S. L. Bogdanova, G. A. Novik

    Published 2021-07-01
    “…Till present, pediatric rheumatologists have not reached a  consensus on this issue yet.The aim of this study was to search for predictors of early failure of local steroid therapy and assessment of its feasibility in patients with oligoarticular JIA.Materials and methods. …”
    Get full text
    Article
  6. 826
  7. 827

    A multidisciplinary dermatology-gastroenterology-rheumatology (DER.RE.GA) unit for the care of patients with immune-mediated inflammatory diseases: analysis of the first 5 years fr... by Valeria Brazzelli, Valeria Brazzelli, Francesca Bobbio Pallavicini, Paolo Maggi, Łukasz Chętko, Łukasz Chętko, Eugenio Isoletta, Nicolò Di Giuli, Alice Bonelli, Valentina Fornaroli

    Published 2023-11-01
    “…A digital database was created, containing the medical records of 146 patients referred to the dermatology unit only by rheumatologists or gastroenterologists belonging to the multidisciplinary unit DERREGA. …”
    Get full text
    Article
  8. 828

    GCF Resistin As A Novel Marker in Patients with Chronic Periodontitis and Rheumatoid Arthritis by Manoj Mittal, Basit Hassan, Khushboo Desai, Shilpa Duseja, Santosh Kumar, Sharaschandra G. Reddy

    Published 2015-04-01
    “…Rheumatoid arthritis was confirmed by the rheumatologists and seropositivity for rheumatoid factor (RF) was checked. …”
    Get full text
    Article
  9. 829

    Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children by Fatih Haslak, Sevki Erdem Varol, Aybuke Gunalp, Ozge Kaynar, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Gulsen Kes, Ayse Ayzit-Kilinc, Beste Akdeniz, Pinar Onal, Gozde Apaydin, Deniz Aygun, Huseyin Arslan, Azer Kilic-Baskan, Evrim Hepkaya, Ozge Meral, Kenan Barut, Haluk Cezmi Cokugras, Ozgur Kasapcopur

    Published 2022-04-01
    “…Furthermore, increasing age was significantly associated with symptomatic infection (OR: 1.051; 95% CI: 1.009–1.095). (4) Conclusions: Our study emphasizes that pediatric rheumatologists should monitor their patients closely for relatively poor COVID-19 outcomes.…”
    Get full text
    Article
  10. 830

    Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases by V. I. Mazurov, I. B. Belyaeva, R. R. Samigullina, A. L. Chudinov, A. M. Dadalova

    Published 2020-07-01
    “…The use of tocilizumab is included in the draft recommendations for the treatment of IID in conditions of coronavirus disease 2019 (COVID-19) developed by the All-Russian public organization “Association of Rheumatologists of Russia”. The presented data from international and domestic studies, as well as our own clinical experience, suggest that Tocilizumab (Actemra) is a highly effective and safe genetic engineering biological drug (GEBD) in the treatment of IID, and its use leads to a decrease in clinical and immunological activity and helps to improve life prognosis both when appointing as a first-line GEBD therapy and in case of ineffectiveness of other biological drugs and basic anti-inflammatory drugs in this category of patients.…”
    Get full text
    Article
  11. 831

    Treat-to-target strategies for the management of familial Mediterranean Fever in children by Lisa Ehlers, Elisabeth Rolfes, Mareike Lieber, Dominik Müller, Elke Lainka, Faekah Gohar, Günter Klaus, Hermann Girschick, Jana Hörstermann, Jasmin Kümmerle-Deschner, Jürgen Brunner, Katharina Palm-Beden, Klaus Tenbrock, Lusine von Wrangel, Maria Faßhauer, Norbert Blank, Ralf Trauzeddel, Anne Sae Lim von Stuckrad, Sonja Higgins, Tatjana Welzel, Thomas Lutz, Véronique Hentgen, Dirk Foell, Helmut Wittkowski, Tilmann Kallinich

    Published 2023-09-01
    “…To ensure the applicability of the statements in daily practice, an online survey was conducted among paediatric rheumatologists in Germany. In addition, data from the national AID-NET registry were analysed with respect to therapeutic response. …”
    Get full text
    Article
  12. 832

    The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis by M. Manara, I. Prevete, A. Marchesoni, S. D'Angelo, A. Cauli, A. Zanetti, A. Ariani, A. Bortoluzzi, S. Parisi, C.A. Scirè, N. Ughi

    Published 2021-08-01
    “…A working group composed of rheumatologists with proven experience in the management of axial SpA and methodologists identified the key research questions which guided study selection and data extraction. …”
    Get full text
    Article
  13. 833
  14. 834

    Web-based eHealth Clinical Decision Support System as a tool for the treat-to-target management of patients with systemic lupus erythematosus: development and initial usability eva... by Ronald van Vollenhoven, Alexandre Voskuyl, Agner Russo Parra Sanchez, Max G Grimberg, Myrthe Hanssen, Moon Aben, Elianne Jairth, Prishent Dhoeme, Michel W P Tsang-A-Sjoe, Hendrik Jan Jansen

    Published 2023-12-01
    “…Background Treat-to-target (T2T) is a therapeutic strategy currently being studied for its application in systemic lupus erythematosus (SLE). Patients and rheumatologists have little support in making the best treatment decision in the context of a T2T strategy, thus, the use of information technology for systematically processing data and supporting information and knowledge may improve routine decision-making practices, helping to deliver value-based care.Objective To design and develop an online Clinical Decision Support Systems (CDSS) tool “SLE-T2T”, and test its usability for the implementation of a T2T strategy in the management of patients with SLE.Methods A prototype of a CDSS was conceived as a web-based application with the task of generating appropriate treatment advice based on entered patients’ data. …”
    Get full text
    Article
  15. 835
  16. 836

    Developing evidence-based patient-focused learning materials to support health behaviour change for people living with psoriatic arthritis by Shona Kirtley, Melissa Stepney, Laura C Coates, Louise Hailey, Christine Bundy, Laura Howells, Samantha Martin, Denis O'Sullivan, Ingrid Steinkoening

    Published 2023-07-01
    “…Our aim was to codesign the project as theory-informed, evidence-based, patient-focused, materials supporting healthy lifestyle changes for patients diagnosed with PsA.Methods Development of the materials was overseen by a steering group of patients with PsA, psychologists, rheumatologists, a design team and researchers. First, a literature review was performed to establish the evidence base for behaviours and potential interventions in PsA, including diet, weight, alcohol, smoking, exercise, anxiety, depression and stress. …”
    Get full text
    Article
  17. 837

    Using thoracic ultrasound to detect interstitial lung disease in patients with rheumatoid arthritis: a protocol for the diagnostic test accuracy AURORA study by Robin Christensen, Torkell Ellingsen, Heidi Lausten Munk, Grith Lykke Sorensen, Philip Rask Lage-Hansen, Jesper Rømhild Davidsen, Stefan M W Harders, Bjørk Khaliqi Sofíudóttir

    Published 2022-12-01
    “…The anonymised TUS images will be stored and scored by the junior resident as well as two senior rheumatologists, who have received training in TUS, and a TUS-experienced pulmonologist. …”
    Get full text
    Article
  18. 838

    Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries by Peter C. Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell

    Published 2023-01-01
    “…Results Three hundred and three rheumatologists provided data for 160 non-switchers and 225 switchers, 140 patients provided data; 51 non-switchers, 89 switchers. …”
    Get full text
    Article
  19. 839

    Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabi... by Cornelis Jan van Dam, Monique van Velzen, Cornelis Kramers, Arnt Schellekens, Erik Olofsen, Marieke Niesters, Albert Dahan

    Published 2023-01-01
    “…Trial population: 60 patients with fibromyalgia according to the 2010 definition of the American College of Rheumatologists. Intervention: Patients will be randomized to receive up to 4 daily 5 mg oral oxycodone sustained release (SR) tablet, up to 5 times 150 mg inhaled cannabis (Bediol®, containing 6.3% Δ9-tetrahydrocannabinol and 8% cannabidiol), or the combination of both treatments. …”
    Get full text
    Article
  20. 840

    Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look by A. V. Gordeev, E. V. Matyanova, Yu. A. Olyunin, E. A. Galushko, E. G. Zotkin

    Published 2022-05-01
    “…At the same time, Russian rheumatologists primarily use GC to suppress inflammatory activity. …”
    Get full text
    Article